Nkonkonsa Celebrity Gossip From Africa
Russia’s Ministry of Health has announced the development of a cancer vaccine, which will be provided to patients free of charge starting in early 2025, according to state-run media reports.
Andrey Kaprin, head of the Radiology Medical Research Center under the Health Ministry, revealed that the vaccine is intended to treat existing cancer patients rather than prevent the disease in the general population.
Details remain scarce regarding the vaccine’s name, targeted cancer types, efficacy, and rollout plan. However, reports suggest the vaccine will be personalized, using RNA-based technology to tailor treatments to individual patients—an approach similar to ongoing research in Western countries.
Personalized cancer vaccines work by training the immune system to recognize and destroy proteins specific to a patient’s cancer cells. By introducing harmless tumor antigens into the body, the immune system produces antibodies that attack cancer cells.
Russia’s announcement comes as cancer cases in the country continue to rise, with over 635,000 cases recorded in 2022. Colon, breast, and lung cancers are among the most prevalent forms of the disease.
Globally, similar breakthroughs are being made in cancer research. In the UK, scientists are testing a personalized melanoma vaccine that has significantly improved survival rates. Meanwhile, researchers at the University of Florida recently reported promising results for a glioblastoma vaccine, which triggered a strong immune response in just 48 hours.
Russia’s move into the cancer vaccine landscape marks a significant step forward in the fight against the disease. However, questions about the vaccine’s development, testing, and effectiveness remain unanswered as the world waits for further details ahead of its 2025 rollout.
Source:NKONKONSA.com
